Alibaba and Tencent Just Wrote Angel Checks to the Same Robot Startup

Alibaba and Tencent compete in almost everything. Cloud, payments, e-commerce, gaming, large language models. The two companies rarely invest together, and almost never at the angel stage, where check sizes are usually too small to interest either. On July 29, a Shenzhen startup barely eleven months old announced it had persuaded both to co-lead its first institutional round, at a scale that rewrites what "angel" means in Chinese venture capital.

Morphi, registered in Shenzhen's Qianhai district in August 2025, disclosed to Southern Metropolis Daily that it has completed an angel-round series exceeding RMB 1 billion (US$140 million). The post-money valuation exceeds RMB 7 billion (US$980 million). Alongside the two internet giants, the cap table now includes Lanchi Ventures, Legend Capital, Huaye Tiancheng, Gaorong Capital, CASSTAR, Source Code Capital, Guanghe Ventures, Borui Capital, and 58 Industry Fund. Gaohu Capital served as exclusive financial adviser. The company says it is the largest publicly disclosed first-round financing in China's embodied intelligence industry.

The Huawei Pedigree Behind the Valuation

The team explains much of the price. Morphi's chief executive, Gao Wenli, spent years running overseas markets at Huawei before co-founding iMile, the Middle East logistics company that became a unicorn on the strength of last-mile delivery in Gulf markets. The chief technology officer, Huang Qingqiu, entered Huawei through its "genius youth" program, the company's elite recruitment track for exceptional young researchers, and rose to lead AI development for Huawei's ADS autonomous driving system, the technology stack behind the assisted-driving features in Aito and Luxeed vehicles.

That resume matters because autonomous driving is the closest thing embodied AI has to a proven training ground. The perception, prediction, and planning stack that keeps a car in its lane is a cousin of the stack that keeps a bipedal robot upright and moving through a hotel corridor. Chinese venture investors have watched autonomous driving talent migrate into humanoid robotics for two years. Morphi is the most expensive expression of that migration so far.

The company is building the full stack, an embodied foundation model, a world model, vision-language-action systems, and its own bipedal hardware. Its commercial sequencing is deliberate. Hotels and last-mile delivery first, where environments are semi-structured and tasks are repetitive. Homes later, when reliability catches up with ambition. Gao's iMile background shows in the choice of delivery as an early wedge.

Why Both Giants Showed Up

Alibaba and Tencent have each been assembling embodied AI portfolios separately. Alibaba led rounds in X Square Robot and has poured capital into its own Qwen model family. Tencent runs its RoboticsX lab and released embodied foundation models at the World AI Conference in July. Their joint appearance in a single angel round signals something specific. Neither wants to be locked out of a potential platform company, and neither trusts the other to share access later.

For the startup, dual sponsorship cuts both ways. The money and cloud resources are enormous, and both groups bring distribution. Alibaba's logistics network and Tencent's WeChat ecosystem are plausible deployment channels for service robots. But history counsels caution. Chinese startups that took money from both giants have sometimes found themselves unable to integrate deeply with either, as each side guards against advantaging the other.

The round also confirms how sharply China's embodied AI capital cycle has steepened. Zhiping Fang raised a record RMB 5 billion single round earlier in July. Delta Intelligence closed its sixth round in six months this week. It took Unitree nine years to reach the valuation Morphi hit in eleven months. The angel round, once a seven-figure bet on two founders and a slide deck, has become a nine-figure bet on a team's pedigree before the first product ships.

The Numbers Deserve a Cold Shower

A RMB 7 billion valuation for an eleven-month-old company with no disclosed revenue, no shipped product, and no public prototype demonstration is a bet on narrative and team, nothing more. The reference points investors are using, Figure's US$39 billion valuation, Unitree's roughly RMB 42 billion market cap at listing approval, are themselves untested by public markets. If the sector reprices, angel investors at RMB 7 billion have the least cushion of anyone in the stack.

The competitive field is also brutally crowded. China now counts at least eight embodied AI companies valued above RMB 20 billion and dozens more above RMB 1 billion. All of them are hiring from the same talent pools, buying the same actuators and sensors, and chasing the same hotel, logistics, and manufacturing pilots. The commercial-first strategy Morphi describes is the same strategy described by AgiBot, Galbot, UniX AI, and a dozen competitors with two-year head starts.

What separates Morphi's bet from the pack is the assumption embedded in its full-stack approach. The company is wagering that the winners of embodied AI will own their models and their hardware together, the Tesla model, rather than specializing in one layer. That thesis is expensive to test. Full-stack humanoid development burns capital on parallel fronts, which is precisely why the round needed to be this large.

The Signal for the Rest of the Market

Every venture ecosystem has a moment when its biggest strategic players stop watching a new sector and start anchoring it. For China's embodied AI industry, the joint Alibaba and Tencent angel is that moment. The two companies that shaped the mobile internet era in China have now both put their names on the earliest, riskiest stage of the humanoid era, in the same company, in the same week that Washington banned Chinese humanoids and Beijing's flagship newspaper declared robots a national export product.

The capital is flowing downhill toward younger and younger companies at higher and higher prices. Whether that is conviction or fear of missing out will only be visible in hindsight. What is visible now is the direction. China's biggest balance sheets have decided that embodied AI is not a sector to observe. It is a sector to own from the seed.

The Logistics Thread Running Through the Story

Gao Wenli's path to humanoid robotics runs through packages, not laboratories. iMile, the company he co-founded after leaving Huawei, built its unicorn valuation on last-mile delivery across the Gulf states, solving cash-on-delivery logistics in markets that Amazon and the Chinese e-commerce giants had struggled to crack. The operational knowledge inside that business, route density, delivery economics, failure rates at the doorstep, is exactly the knowledge a humanoid delivery robot company needs and almost never has.

This is why Morphi's commercial sequencing reads differently from its competitors' pitch decks. When a research-born humanoid startup says it will start with delivery, it is guessing at an application. When a founder who ran delivery networks across seven countries says it, he is describing a cost curve he has already lived. The unit economics of last-mile delivery are brutal and well understood. A robot that can complete doorstep handoffs reliably would attack the single largest cost line in the business. Gao knows precisely what reliability threshold and cost-per-delivery a machine must hit before it displaces a human courier, because he has employed thousands of them.

The Shenzhen Qianhai registration is equally deliberate. Qianhai's special economic zone status offers preferential tax treatment and streamlined cross-border capital rules, useful for a company whose founding team built its careers in overseas markets and whose first commercial deployments may not be in China at all. A humanoid delivery pilot in Dubai or Riyadh, markets iMile knows intimately and where regulators move fast, would sidestep both the crowded Chinese pilot landscape and the closed American one.

How the Round Reprices Everyone Else

Venture rounds are information events. Every embodied AI founder in China walked into this week knowing that the bar for a first institutional round now sits at a level that did not exist in June. Seed-stage companies that raised at RMB 300 million valuations last year will demand re-pricing. Investors holding early positions in second-tier humanoid startups just received a paper markup courtesy of Morphi's comparables. And the limited partners behind China's yuan funds, many of them provincial guidance funds with mandates to deploy into hard technology, now have a fresh data point proving the sector can absorb billion-yuan checks.

The mechanism feeds itself. Higher valuations attract better founders, who attract more capital, which raises valuations again. The cycle continues until a public market listing tests the private marks against real demand. Unitree's Hong Kong debut, expected within months, will be that test. If it trades well, the Morphi round will look prescient. If it breaks issue price, every angel investor who paid unicorn prices for pre-product robotics companies will be marking down the same week. The entire Chinese embodied AI capital structure now leans on a handful of upcoming listings, which is precisely the kind of concentration that makes venture markets interesting and dangerous at the same time.

Morphi's founders appear to understand the clock. The commercial-first sequencing, hotels and last-mile delivery before home robotics, is designed to generate revenue data before the listing window closes. A company that can show paying customers and unit economics at its Series A will command a different conversation than one that shows only research progress. The angel round buys roughly 18 months of runway at current burn rates. The product must ship, and the revenue must start, inside that window. Everything else is narrative.

Disclaimer: This article is for informational purposes only and does not constitute investment advice, endorsement, or verification of any claims made by the companies mentioned.